secwatch.observer — SEC 8-K summary
======================================

Issuer:     PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
CIK:        0001299130
Form:       8-K
Filed at:   2024-08-07T23:59:59+00:00
Accession:  0001299130-24-000164
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PacBio Q2 revenue down 24% to $36M; GAAP net loss $173M includes $93M goodwill impairment
--------------------------------------------------------------------------------

- Revenue of $36.0M vs $47.6M YoY; instrument revenue fell to $14.7M from $29.9M.
- GAAP net loss $173.3M (-$0.64/sh); non-GAAP net loss $55.2M (-$0.20/sh).
- Goodwill impairment charge of $93.2M; restructuring expenses of $18.0M included.
- Cash $509.8M, down from $631.4M at Dec 31, 2023.
- CEO expects revenue acceleration in H2; targeting >$75M annual expense reduction.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1299130/000129913024000164/0001299130-24-000164-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1299130/000129913024000164/pacb-20240807.htm
  HTML page:      https://secwatch.observer/filing/0001299130-24-000164

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer